Skip to main content
TipRanks
Go Ultimate75% OFF

Mosaic Co (02M) AI Stock Analysis

4 Followers
CH:02M

Mosaic Co

(BX Swiss:02M)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Balance Sheet ResilienceMosaic has meaningful financial flexibility because management reports no long-term obligations over the next two years and has extended upcoming maturities. This reduces near-term refinancing pressure and preserves capacity to manage the fertilizer downturn, fund operations, and allocate capital selectively.
Negative Factors
Weak Profitability and Cash FlowThe latest financial profile shows materially reduced earnings power, with sharply compressed gross margin, a net loss, and negative free cash flow. Although operating cash flow remains positive, weaker conversion and higher spending constrain internal funding and make recovery dependent on improved market conditions.

Mosaic Co (02M) vs. iShares MSCI Switzerland ETF (EWL)

-20%-10%0%10%20%CH:02M-18.83%EWL+14.75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CHF 7.25B
Dividend Yield
4.31%
Average Volume (3M)
167
Price to Earnings (P/E)
-17.1
Beta (1Y)
-0.28
Revenue Growth
-5.93%
EPS Growth
-186.35%
Country
Switzerland
Employees
13,249
Sector
General
Sector Strength
55
Industry
Agricultural Inputs

Mosaic Co Business Overview & Revenue Model

Company Description

Operating on a global scale via its various subsidiaries, The Mosaic Company specializes in the creation and distribution of concentrated phosphate and potash crop nutrients. Its business is structured into three distinct segments: Phosphates, Potash...

Mosaic Co Earnings Call Summary

Earnings Call Date:Nov 03, 2026(Q3-2026)|% Change Since:0.00%|Next Earnings Date:Feb 24, 2027
Earnings Call SentimentPositive

The call had a cautiously positive overall tone. Management emphasized a difficult phosphate environment, sulfur-driven curtailments, reduced phosphate application, and a fourth-quarter EBITDA trough, but highlighted positive free cash flow expectations, balance-sheet flexibility, cost reductions, improving phosphate demand, strong potash fundamentals, operational improvements, and strong Biosciences growth.

Positive Updates

Positive Free Cash Flow Despite Production Curtailments
Mosaic expects to generate positive free cash flow in the second half of 2026 despite production curtailments in the United States and Brazil. The company is managing production to match affordable sulfur availability, idling South Fort Meade and Misquimayo to reduce rock inventory, preserve cash, and align mining with current production.

Negative Updates

Difficult Phosphate Market and Production Curtailments
Mosaic described the phosphate market as difficult and has curtailed production at Bartow, Louisiana, and in Brazil because affordable sulfur availability is insufficient. The company said current spot sulfur prices are producing unsustainably low stripping margins for some producers, and current economics remain insufficient for a meaningful recovery in global phosphate supply.

Company Guidance

Mosaic expects positive free cash flow in the second half of this year, fourth-quarter sulfur costs of $800 to $850 per ton, ammonia costs of $590 to $610 per ton, and realized stripping margins in the mid-$300s per ton; its fourth quarter contract sulfur price is $615 per ton. It expects 2026 SG&A to be $510 million to $530 million and 2027 SG&A to be below $500 million, while targeting 2027 capital expenditures of below $1 billion, roughly $200 million below where we expect to finish 2026. Mosaic continues to target annual potash production of more than 9 million tons over the longer term, with Esterhazy on pace for over 5 million tons of production in 2027, and expects Mosaic Biosciences to generate nearly $135 million in 2026, launch 8 to 10 new products this year, deliver positive EBITDA, and pursue its goal of generating $200 million of EBITDA from the business by 2030. It has sulfur going into 2027 to meet about 65-66% of its production needs, expects global phosphate shipments to be down approximately 20 million tons from last year with this trend carrying over into 2027, and said Q4 is gonna be a trough in terms of EBITDA especially in the phosphate segment.

Mosaic Co Risk Analysis

Mosaic Co disclosed 45 risk factors in its most recent earnings report. Mosaic Co reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

Mosaic Co Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

CH:02M against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IPIIPI65Neutral$446.37M17.944.81%―5.04%―
UANUAN65Neutral$1.19B11.2235.58%12.81%7.31%-16.36%
CTVACTVA64Neutral$8.12B7.624.08%0.89%3.70%-26.39%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
ICLICL55Neutral$6.03B18.965.02%4.51%10.15%-15.98%
FMCFMC42Neutral$877.35M-0.17-308.88%5.66%-21.99%-677.23%

* General Sector Average

Performance Comparison

-50%0%50%CH:02MUANFMCIPIICLCTVADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:02M and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CH:02MMosaic Co14.76-3.42-18.83%
UANCVR Partners LP112.9221.8523.99%
FMCFMC Corp5.65-7.89-58.27%
IPIIntrepid Potash Inc32.976.7725.84%
ICLIcl Group Ltd.4.57-0.70-13.23%
CTVACorteva12.142.3323.76%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.